摘要目的 通过改变原噬菌体ms2包膜蛋白RNA包装位点(19碱基的茎环结构)的数量及亲和力,构建新的原核表达系统,探讨表达内含长片段(达到理论上的1 900 bp)RNA的耐RNase病毒样颗粒的可能性.方法 首先设计含Hind Ⅲ和Not Ⅰ酶切位点的引物,扩增ms2包膜蛋白的编码成熟酶蛋白和衣壳蛋白的1 700 bp序列,并将原来的19mer的包装位点序列改变为C-5变异体(19 bp stem-loop结构中-5位的尿嘧啶改变为胞嘧啶),Hind Ⅲ和Not Ⅰ酶切后,与用同样酶切的表达载体pET-28(b)相连接,得到重组载体pET-ms2-pac.应用重叠PCR扩增3种病毒的5段嵌合体序列(包括3段SARS-CoV基因、一段HCV基因和一段HSN1基因),并在SARS-CoV3和HCV序列之间插入一个19mer的变异体包装位点序列,在设计引物时,使嵌合体两端含有Not Ⅰ酶切位点,与Not Ⅰ酶切的重组载体pET-ms2-pac相连接,构建得到具有2个变异包装位点的表达载体pET-ms2-3V.同时构建3种对照重组表达载体,分别测定N-P3V-pET-P、N-P3V-pET-C、P-3V-pET-P和pET-ms2-3V 4种重组表达质粒表达产物的260 nm吸光度(A260)值,根据公式A160=0.125 mg/ml计算4种表达产物的表达效率.结果 成功构建了4种原核表达载体:pET-ms2-3V、P-3V-pET-P、N-P3V-pET-P和N-P3V-pET-C.pET-ms2-3V和P-3V-pET-P经原核表达后得到含全长为1 891的5段嵌合体RNA的病毒样颗粒;N-P3V-pET-P、N-P3V-pET-C其原核表达产物病毒样颗粒中仅包装了1 200 bp的目的 嵌合体RNA.N-P3V-pET-P、N-P3V-pET-C、P-3V-pET-P和pET-ms2-3V的表达效率分别为0.23、0.35、0.35和0.51 mg/ml.N-P3V-pET-C比N-P3V-pET-P表达效率高52%,而pET-ms2-3V比P-3V-pET-P表达效率高38%.所包装的RNA具有耐RNase和DNase消化的特性以及良好的不同温度条件下的稳定性.结论 通过改变噬菌体ms2 RNA包装位点(19碱基的茎环结构)的数量,可构建能表达内含达到理论上的约1 900 bp外源RNA的耐RNase病毒样颗粒的原核表达载体平台.通过应用包装位点的变异体C-变异体,可以增加病毒样颗粒的表达效率.

abstractsObjective To construct and express ribonuclease-resistant virus-like particles containing long chimeric RNA sequence by changing quantity and affinity of ms2 19mer stem-loop.Methods 1.7 kb maturase and coat protein gene of ms2 were amplified.We used a C-variant aptamer of the wild-type stem-loop where uridine-5 has been substituted by cytosine.The 1700 bp PCR-amplified DNA fragments was gel-purified and then digested with BamH Ⅰ and Hind Ⅲ and ligated to linearized pET28b vector to generate recombinant plasmid pET-MC-pac.The five target DNA sequences were spliced by overlapping extension(including 3 fragment of SARS-CoV,one fragment of HCV and one fragment of HSN1).PCR was carried out using primers contained Not Ⅰ site and then PCR were cloned into a pGEM(R) T-easy vector and then excised with the Not Ⅰ restriction enzymes from the resulting recombinant plasmid.simoutaniously the pET-MC-pac plasmid was digested with Not Ⅰ restriction enzymes,fragments were ligated into the linearized pET-MC-pac plasmid to produce a new donor plasmids pET-MC-3V.Simoutaniously,we constructed three recombinant expression vector for control,including N-P3V-pET-P、N-P3V-pET-Cand P-3V-pET-P.N-P3V-pET-P contained one wild type pacsite located behind ms2 sequence:N-P3V-pET-C contained one C-variant pacsite located behind ms2 sequence:P-3V-pET-P contained two wild type pacsites that one is located behind ms2 sequence,another is located between SARS-CoV 3 and HCV sequence.Then these four expression vector were transformed into E.coli strain BL21(DE3),respectively.The 3V Armored RNA was expressed and purified.A260 absorbance value of expression product was determined.Results Four expression plasmids were constructed successfully.The Armored RNA with 1891 bases was snccessfully expressed by the two-paesite expression system of pET-ms2-3V and P-3V-pET-P;for N-P3V-pET-P、N-P3V-pET-C,only 1 200 bp target sequence was packaged into virus-like particles.Expression efficiency of N-P3V-pET-P、N-P3V-pET-C、P-3V-pET-P and N-P3V-pET-P was 0.23,0.35,0.35,0.51 mg/ml,respectively.Armored RNA was shown to have the charaeterization of Ribonuclease-resistant and stable at 4℃,37℃ and 25℃ respectively.Conclusion The expression plasmids containing two pacsites were constructed successfully and prokaryotic expression system can be used as an expressing plasmid platform for preparation of Ribonuclease-resistant virus-like particles containing long chimeric RNA sequence.